PetVivo Holdings, Inc. (PETV): R&D Expense
$1.42M
Year ended 2026-03-31
$1.31M
Trailing 12 months to 2026-06-30
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $1.42M | -10.6% | 2026-06-29, From 2025-04-01 |
| 2025-03-31 | $1.58M | +13.5% | 2026-06-29, From 2024-04-01 |
| 2024-03-31 | $1.40M | n/c | 2025-07-10, From 2023-04-01 |
| 2023-03-31 | $996.4K | n/c | 2024-06-28, From 2022-04-01 |
| 2022-03-31 | $474.9K | +383.4% | 2023-06-29, From 2021-04-01 |
| 2021-03-31 | $98.2K | +675.2% | 2022-06-24, From 2020-04-01 |
| 2020-03-31 | $12.7K | -93.7% | 2021-06-29, From 2019-04-01 |
| 2019-03-31 | $201.0K | +69.0% | 2020-06-29, From 2018-04-01 |
| 2018-03-31 | $118.9K | -29.2% | 2019-07-31, From 2017-04-01 |
| 2017-03-31 | $167.9K | -0.4% | 2018-11-14, From 2016-04-01 |
| 2016-03-31 | $168.6K | n/m | 2018-11-14, From 2015-04-01 |
| 2015-03-31 | $4.4K | n/a | 2016-08-17, From 2014-04-01 |
| No annual figure between 2012-03-31 and 2015-03-31. | |||
| 2012-03-31 | $0 | -100.0% | 2012-07-17, From 2011-04-01 |
| 2011-03-31 | $157.3K | n/a | 2012-07-17, From 2010-04-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $1.42M | -10.6% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $6.27M | +4.0% |
| SeaStar Medical Holding Corp (ICU) | 2025-12-31 | $7.52M | -17.4% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $4.59M | -11.8% |
| Catheter Precision, Inc. (VTAK) | 2025-12-31 | $862.0K | +216.9% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $23.94M | -11.5% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $2.65M | +14.8% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $10.0K | -35.0% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $19.14M | -8.8% |
Compare PETV, RNXT, ICU, SINT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗